Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Pathologic Neovascularization. Found 19 abstracts

Greten FR, Grivennikov SI. Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity. 2019 Jul 16;51(1):27-41.   PMCID: PMC6831096
Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer. 2017 Oct 24;117(11):1583-91.   PMCID: PMC5729447
Fu H, Vadalia N, Xue ER, Johnson C, Wang L, Yang WY, Sanchez C, Nelson J, Chen Q, Choi ET, Ma JX, Yu J, Wang H, Yang X. Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study. Journal of hematology & oncology. 2017 Mar 23;10(1):74.   PMCID: PMC5364721
Lecht S, Chiaverelli RA, Gerstenhaber J, Calvete JJ, Lazarovici P, Casewell NR, Harrison R, Lelkes PI, Marcinkiewicz C. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki. Biochimica et biophysica acta. 2015 Jun;1850(6):1169-79.
Meng MB, Zaorsky NG, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Pericytes: a double-edged sword in cancer therapy. Future Oncol. 2015 Jan;11(1):169-79.
Lee S, Goldfinger LE. RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells. FASEB J. 2014 Sep;28(9):4158-68.   PMCID: 4139904
Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 2009 Mar;112(3):583-9.   PMCID: PMC2858218
Haas NB, Uzzo RG. Tyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer. Current treatment options in oncology. 2007 Jun;8(3):211-26.
Bassi DE, Klein-Szanto A. Proprotein convertases, metalloproteases and tumor cell invasion. In: Khatib AM, editor. Regulation of carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs) : a new potential strategy in cancer therapy. Dordrecht, The Netherlands: Springer; 2006. p. 89-106.
Lopez de Cicco R, Bassi DE, Zucker S, Seidah NG, Klein-Szanto AJ. Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Research. 2005 May 15;65(10):4162-71.
Chapman JD, Bradley JD, Eary JF, Haubner R, Larson SM, Michalski JM, Okunieff PG, Strauss HW, Ung YC, Welch MJ. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys. 2003 Feb;55(2):294-301.
Meyers MO, Watson JC. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am. 2003 Jan;12(1):151-63.
Zhang L, Yang N, Katsaros D, Huang W, Park JW, Fracchioli S, Vezzani C, Rigault de la Longrais IA, Yao W, Rubin SC, Coukos G. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Cancer Res. 2003 Jul 15;63(14):4225-31.
Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun. 2003 Apr 18;303(4):1169-78.
Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003 Jun 15;63(12):3403-12.
Ruggeri BA, Robinson C, Angeles T, Wilkinson Jt, Clapper ML. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. Clin Cancer Res. 2002 Jan;8(1):267-74.
Hazelton DA, Hamilton TC. Vascular endothelial growth factor in ovarian cancer. Current oncology reports. 1999 Sep;1(1):59-63.
Watson JC, Sutanto-Ward E, Osaku M, Weinstein JK, Babb JS, Sigurdson ER. Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic metastases in BD-IX rats. Surgery. 1999 Aug;126(2):358-63.
Ma J, Fei ZL, Klein-Szanto A, Gallo JM. Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor. Clin Exp Metastasis. 1998 Aug;16(6):559-68.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Pathologic Neovascularization

Pathologic Neovascularization blood supply metabolism pathology Human genetics drug therapy Non-US Gov't Support Neoplasms Endothelial Growth Factors Angiogenesis Inhibitors Cultured Tumor Cells Mice therapeutic use US Gov't Support-PHS physiology Female Vascular Endothelial Growth Factor A drug effects pharmacology Lymphokines Animal Ovarian Neoplasms Male Cell Hypoxia Intercellular Signaling Peptides and Proteins Biological Tumor Markers Neoplastic Gene Expression Regulation Rats immunology physiopathology Vascular Endothelial Growth Factors biosynthesis Neoplasm Proteins Vascular Endothelium Colorectal Neoplasms methods Cell Division secondary Carcinoma Enzyme Inhibitors Heterologous Transplantation Glioma Pericytes Angiogenic Proteins prevention & control antagonists & inhibitors analysis Vascular Endothelial Growth Factor Receptors Endothelial Cells Neoplasm Metastasis radiotherapy Transfection Genetic Vectors Neoplasm RNA Neoplasm Invasiveness Tumor Cell Line Tumor Microenvironment enzymology Messenger RNA Liver Physiologic Neovascularization Drug Dose-Response Relationship Cell Surface Receptors Apoptosis Cell Proliferation Receptor Protein-Tyrosine Kinases Neoplastic Stem Cells Viper Venoms Protein Precursors Uterine Cervical Neoplasms Data Mining Hypoxia-Inducible Factor 1 Adult Antisense DNA Capillaries neovascularization Proprotein Convertases Western Blotting 0 (Peptide Fragments) Research Middle Aged Disease Progression blood toxicity Autoimmunity diagnostic use Recombinant Fusion Proteins Carcinogenesis Homeostasis Transcriptional Activation radiography Non-US Gov't Research Support Migration Peptide Fragments anti-angiogenesis therapy Acute Coronary Syndrome Leukocytes secretion neoplasms Experimental Liver Neoplasms Catalytic Domain Fibroblast Growth Factor Receptors Transcriptome Cell Transdifferentiation Nude Rats Oligonucleotide Array Sequence Analysis 0 (Protein Precursors) Carcinogens Immunohistochemistry purification Angiogenesis Emission-Computed Tomography Dacarbazine Liver Neoplasms X-Ray Computed Tomography Scanners Nude Mice Biological Models Angiopoietin-2 Growth Substances Sesquiterpenes Hemangiosarcoma angiogenesis therapy cell plasticity etiology Platelet-Derived Growth Factor Phosphatidylinositol 3-Kinases cytology Crisp Experimental Melanoma Protein Isoforms Transformed Cell Line Amino Acid Sequence ge [Genetics] Lewis Lung Carcinoma isolation & Aorta GTPase-Activating Proteins Antineoplastic Antibiotics Paracrine Communication Kidney Neoplasms Quail Platelet-Derived Growth Factor beta Receptor Fludeoxyglucose F 18 Prognosis Pancreatic Ribonuclease Protein Kinase Inhibitors tumor microenvironment EC 3-4-21-75 (Furin)
Last updated on Friday, August 14, 2020